Compound Detail
CHEMBL5410965
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5410965 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SQGAIPFCRMARST-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
346.4
MW (Da)
3.09
ALogP
4
HBA
1
HBD
62.5
PSA (Ų)
0.77
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.02
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Complement C1s subcomponent CHEMBL3913 | IC50 | 4.02 | 4.02 | 96000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Complement C1s subcomponent | IC50 | = | 96000.0 | nM | 4.02 | Inhibition of human recombinant N-terminal IgG tagged and C-terminal His tagged ... | 37120845 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37120845 | 10.1021/acs.jmedchem.3c00348 | Complement C1s subcomponent | 1 |
Data from ChEMBL 36 via Core Engine